PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $229,000 | -61.1% | 4,304 | -57.4% | 0.08% | -60.5% |
| Q2 2022 | $589,000 | -24.6% | 10,100 | -1.3% | 0.22% | -12.6% |
| Q1 2022 | $781,000 | +32.8% | 10,232 | +4.8% | 0.25% | +35.2% |
| Q4 2021 | $588,000 | -33.9% | 9,768 | -38.6% | 0.18% | -37.7% |
| Q3 2021 | $890,000 | -7.8% | 15,897 | 0.0% | 0.29% | -4.9% |
| Q2 2021 | $965,000 | +11.2% | 15,897 | +28.4% | 0.31% | +7.0% |
| Q1 2021 | $868,000 | +21.6% | 12,379 | +3.8% | 0.29% | +13.0% |
| Q4 2020 | $714,000 | +88.9% | 11,927 | +89.6% | 0.25% | +67.1% |
| Q3 2020 | $378,000 | – | 6,290 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |